• No results found

Therapeutic arteriogenesis: from experimental observations towards clinical application [cum laude] - LIST OF PUBLICATIONS

N/A
N/A
Protected

Academic year: 2021

Share "Therapeutic arteriogenesis: from experimental observations towards clinical application [cum laude] - LIST OF PUBLICATIONS"

Copied!
5
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl)

UvA-DARE (Digital Academic Repository)

Therapeutic arteriogenesis: from experimental observations towards clinical

application [cum laude]

van Royen, N.

Publication date

2003

Link to publication

Citation for published version (APA):

van Royen, N. (2003). Therapeutic arteriogenesis: from experimental observations towards

clinical application [cum laude].

General rights

It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s)

and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open

content license (like Creative Commons).

Disclaimer/Complaints regulations

If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please

let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material

inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter

to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You

will be contacted as soon as possible.

(2)
(3)

van Roy en N, Jaffe CC, Krumholz HM, Johnson KM, Lynch PJ, Natale D, Atkinson P, Deman P, Wackers FJ. Comparison and reproducibility of visual echocardiography and quantitative radionuclide left ventricular ejection fractions.

Am J Cardiol. 1996 Apr 15; 77(10): 843-50

Deindl E, Fernandez B, Hoefer I, van Royen N, Scholz D, Schaper W. Arteriogenesis, Collateral blood vessels and their development.

„Angiogenesis in Health and Disease". Edited by G. Rubyani, Marcel Dekker, Inc., New York, 1999.

Hoefer IE, van Royen N, Buschmann IR, Piek JJ, Schaper W. Time course of arteriogenesis following femoral artery occlusion in the rabbit.

Cardiovasc Res. 2001 Feb 16;49(3):609-17.

Voskuil M, van Royen N, Hoefer I, Buschmann I, Schaper W, Piek JJ. Angiogenesis and arteriogenesis; the long road from concept to clinical Application. Ned Tijdschr Geneeskd. 2001 Apr 7;145(14):670-5. van Royen N, Piek JJ, Buschmann I, Hoefer I, Voskuil M, Schaper W. Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease. Cardiovasc Res. 2001 Feb 16;49(3):543-53.

Deindl E, Buschmann I, Hoefer IE, Podzuweit T, Boengler K, Vogel S, van Royen N, Fernandez B, Schaper W. Role of ischemia and of hypoxia-inducible genes in arteriogenesis after femoral artery occlusion in the rabbit.

Ctc Res. 2001 Oct 26; 89(9): 779-86.

Van Royen N, Piek JJ, Schaper W, Bode C, Buschmann I. Arteriogenesis: mechanisms and modulation of collateral artery development.

/ Nucl Cardiol. 2001 Nov-Dec; 8(6): 687-93.

van Royen N, Hoefer I, Buschmann I, Heil M, Kostin S, Deindl E, Vogel S, Korff T, Augustin H, Bode C, Piek JJ, Schaper W. Exogenous application of transforming growth factor beta 1 stimulates arteriogenesis in the peripheral circulation. FASEBJ. 2002 Mar; 16(3):432-4.

Hoefer IE, van Royen N, Rectenwald JE, Bray EJ, Abouhamze Z, Moldawer LL, Voskuil M, Piek JJ, Buschmann IR, Ozaki CK. Direct evidence for tumor necrosis factor-alpha signaling in arteriogenesis.

Ciicula Hon. 2002 Apr 9; 105(14): 1639-41.

Deindl E, Boengler K, van Royen N, Schaper W. Differential expression of GAPDH and beta3-actin in growing collateral arteries.

Mol Cell Biochem. 2002 Jul;236(l-2): 139-46.

(4)

LIST OF PUBLICATIONS Buschmann IR, Hoefer IE, van Royen N, Katzer E, Braun-Dulleaus R, Heil M, Kostin S, Bode C, Schaper W. GM-CSF: a strong arteriogenic factor acting by amplification of monocyte function. Atherosclerosis. 2001 Dec; 159(2):343-56. van Royen N, Hoefer I, Buschmann I, Kostin S, Voskuil M, Bode Ch, Schaper W, Piek J J. Effects of local MCP-1 protein therapy on the development of the collateral circulation and atherosclerosis in Watanabe hypciiipidemic rabbits.

Cardiovasc Res. 2003 Jan;57(l): 178-85.

van Royen N, Hoefer I, Bottinger M, Hua J, Grundmann S, Voskuil M, Bode C, Schaper W, Buschmann I, Piek JJ. Local monocyte chemoattractant protein-1 therapy increases collateral artery formation in apolipoprotein E-dcficient mice but induces systemic monocytic CD1 lb expression, neointimal formation, and plaque progression. CkcRes. 2003 Feb 7;92(2):218-25.

Buschmann IR, Voskuil M, van Royen N, Hoefer IE, Scheffler K, Grundmann S, Hennig J, Schaper W, Bode C, Piek J J. Invasive and non-invasive evaluation of spontaneous arteriogencsis in a novel porcine model for peripheral arterial obstructive disease. Atherosclerosis. 2003 Mar;167(l):33-43.

Voskuil M, Van Royen N, Hoefer IE, Seidler R, Guth BD, Bode C, Schaper W, Piek J J, Buschmann IR. Modulation of collateral artery growth in a porcine hindlimb ligation model using MCP-1.

Am J Physiol Heart Ore Physiol. 2003 Apr;284(4):H1422-H1428.

van Royen N. MCP-1, collateral artery development and atherosclerosis

Invited review, in preparation

Voskuil M, Hoefer IE, van Royen N. Arteriogencsis in mice

„Basic Science for the Cardiologist". Edited by Prof. Swyngedauw, Kluwer Academic Publishers, in press

van Royen N, Voskuil M, Hoefer I, Jost M, de Graaf S, Hedwig F, Andert JP, Wormhoudt TAM, Hua J, Hartmann S, Bode C, Buschmann I, Schaper W, van der Neut R, Piek J J, Pals ST. CD44 mediates collateral artery development

Submitted for publication

Hoefer IE, van Royen N, Rectenwald JE, Deindl E, Hua J, Jost M, Grundmann S, Voskuil M, Ozaki CK, Piek JJ, Buschmann I. Arteriogenesis requires 1CAM-1 mediated monocyte adhesion

Revised version submitted to Ckculation

(5)

Referenties

GERELATEERDE DOCUMENTEN

The different SFH’s are coded by line styles: dashed corresponds to the exponential SFH with 1 Gyr timescale, dash-dotted and dotted corresponds to the double-burst with mass

1) Nobody knows if you will benefit directly from this sub-study. Benefit from this sub-study cannot be guaranteed. 2) In general, the HbA1c test may reveal an increased

A Type Laundering design uses object factories and abstract classes to hide vendor specific data structures, and hardware abstraction internals, from application layer

Tyrosine Kinase and Protein Kinase A Modulation of α7 Nicotinic Acetylcholine Receptor Function on Layer 1 Cortical..

At the time, I worked for the research firm hired to conduct the traditional knowledge and use study (herein referred to as the TK study) for this EA as a research assistant. The

Table 4.15: Time Taken to Read Gradients and Update Global Model (seconds) Once updated, the global model updated weights are then pushed to the data server and the worker is

I’ve always known that – never really heard it – always known – the mamulthnii system – the mamulthnii process – when I was doing welfare courses ions ago – DIA –

S7: In the S7 state, it waits for a valid ASCII character, once the character get detected, i.e., ASCII_valid_in = “0-9, a-f, A-F” it moves to S6 state and starts to load